Supplementary video 2 from Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

<p>Video S2</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Alvaro Teijeira (14962650) (author)
Autres auteurs:	Saray Garasa (14962653) (author), Carlos Luri-Rey (14962656) (author), Carlos de Andrea (14962659) (author), Maria Gato (14962662) (author), Carmen Molina (14962665) (author), Tsuneyasu Kaisho (14962668) (author), Assunta Cirella (14962671) (author), Arantza Azpilikueta (14962674) (author), Steffanie K. Wculek (14962677) (author), Josune Egea (14962680) (author), Irene Olivera (14962683) (author), Inmaculada Rodriguez (14962686) (author), Ana Rouzaut (14962689) (author), Vladislav Verkhusha (14962692) (author), Karmele Valencia (14962695) (author), David Sancho (14962698) (author), Pedro Berraondo (14931434) (author), Ignacio Melero (14962701) (author)
Publié:	2025
Sujets:	Cancer Immuno-oncology Immunology Dendritic cells Immune responses to cancer Immunotherapy Agonist antibodies Checkpoint blockade
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires